Latigo Biotherapeutics, Inc.
LTGO
IPO
$22.76
-$0.04-0.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 55.00M | 42.18M | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 3.32M | 2.70M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 876.00K | 1.97M | -- | ||
| Total Current Assets | 59.20M | 46.84M | -- | ||
|
|
|||||
| Total Current Assets | 59.20M | 46.84M | -- | ||
| Net Property, Plant & Equipment | 1.76M | 900.00K | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 3.80M | 2.84M | -- | ||
| Total Assets | 64.76M | 50.58M | -- | ||
|
|
|||||
| Total Accounts Payable | 3.57M | 4.46M | -- | ||
| Total Accrued Expenses | 12.26M | 9.53M | -- | ||
| Short-term Debt | 29.90M | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 705.00K | 502.00K | -- | ||
| Total Finance Division Other Current Liabilities | 5.15M | -- | -- | ||
| Total Other Current Liabilities | 5.15M | -- | -- | ||
| Total Current Liabilities | 51.58M | 14.49M | -- | ||
|
|
|||||
| Total Current Liabilities | 51.58M | 14.49M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | 29.90M | -- | -- | ||
| Capital Leases | 648.00K | 52.00K | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 35.00K | 35.00K | -- | ||
| Total Liabilities | 52.26M | 14.58M | -- | ||
|
|
|||||
| Common Stock & APIC | 15.81M | 13.51M | -- | ||
| Retained Earnings | -291.89M | -266.09M | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -276.08M | -252.58M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | 288.58M | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | 288.58M | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | 288.58M | 288.58M | -- | ||
|
|
|||||
| Total Common Equity | -276.08M | -252.58M | -- | ||
| Total Preferred Equity | 288.58M | 288.58M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 12.50M | 36.00M | -- | ||
|
|
|||||